BRIEF published on 05/29/2024 at 23:50, 1 year 6 months ago Perk Labs Inc. Updates on MCTO Status Financial Statements MCTO BCSC Perk Labs Audit Delay
PRESS RELEASE published on 05/29/2024 at 23:45, 1 year 6 months ago Perk Labs Inc. Provides Update on Status of MCTO Perk Labs Inc. provides an update on the management cease trade order (MCTO) by the BCSC due to delays in financial filings, with no impact on other shareholders' ability to trade Shareholders Perk Labs Inc. Management Cease Trade Order BCSC Financial Filings
BRIEF published on 05/07/2024 at 23:50, 1 year 6 months ago Perk Labs Inc. Provides Update on Status of Management Cease Trade Order Perk Labs Inc. MCTO Financial Reporting Securities Regulation NP 12-203
PRESS RELEASE published on 05/07/2024 at 23:45, 1 year 6 months ago Perk Labs Inc. Provides Update on Status of MCTO Perk Labs Inc. provides update on management cease trade order application granted by the British Columbia Securities Commission, aiming to file annual financial statements by May 31, 2024 Perk Labs Inc. Management Cease Trade Order Annual Financial Statements British Columbia Securities Commission NP 12-203
BRIEF published on 04/26/2024 at 01:55, 1 year 7 months ago Perk Labs Inc. Completes Non-Brokered Private Placements Private Placement Convertible Debentures Stock Market Financial Strategy Perk Labs
PRESS RELEASE published on 04/26/2024 at 01:50, 1 year 7 months ago Perk Labs Announces Closing of Non-Brokered Private Placements Perk Labs Inc. announced the closure of non-brokered private placements of units and convertible debentures, raising CAD $789,000 and $25,000, respectively, for working capital and operational needs Working Capital Perk Labs Inc. Private Placements Units Convertible Debentures
BRIEF published on 04/19/2024 at 04:30, 1 year 7 months ago Perk Labs Inc. Provides Update on Management Cease Trade Order Status MCTO Financial Compliance Audited Financial Statements Perk Labs Regulatory Guidelines
PRESS RELEASE published on 04/19/2024 at 04:25, 1 year 7 months ago Perk Labs Inc. Provides Update on Status of MCTO Perk Labs Inc. provides an update on the management cease trade order application to the British Columbia Securities Commission, granting additional time for filing financial statements Financial Statements Perk Labs Inc. Management Cease Trade Order MCTO British Columbia Securities Commission
BRIEF published on 04/16/2024 at 14:35, 1 year 7 months ago Perk Labs Inc. Announces Progress on New App for Carleton University Students' Association Perk Labs Inc. Mobile App Loyalty Program Getit Technologies Student Engagement
PRESS RELEASE published on 04/16/2024 at 14:30, 1 year 7 months ago Perk Labs Inc. Provides Update on Native App for CUSA Perk Labs Inc. announces rollout of full native app for Carleton University Students' Association, featuring loyalty points and expanded payment options, aiming to boost revenue and student engagement Perk Labs Inc. Carleton University Students' Association Native App Loyalty Points Payment Options
Published on 12/05/2025 at 02:35, 4 hours 42 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 17 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 12 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 17 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 16 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 2 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 17 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 32 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 32 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
